ArticleFrontiers in oncology2025

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.

David Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.